Back
ALPS Active Equity Opportunity ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
78
RFFC
ALPS Active Equity Opportunity ETF
Last Price:
54.17
Seasonality Move:
3.3%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
40.44
Seasonality Move:
-0.9%
Buy
78
ALPS Active Equity Opportunity ETF (RFFC)
is a Buy
Is ALPS Active Equity Opportunity ETF a Buy, Sell or Hold?
- The current ALPS Active Equity Opportunity ETF [RFFC] share price is $54.29. The Score for RFFC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- RFFC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RFFC Stock Price Chart
What is ALPS Active Equity Opportunity ETF's stock price today?
-
The ALPS Active Equity Opportunity ETF share price today is $54.29
The current trend is moderately bullish and RFFC is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
RFFC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 65.93 | Buy |
Chaikin Money Flow: | 554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.96 - 54.08) | Buy |
Bollinger Bands (100): | (50.64 - 53.32) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | 84619 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Sell |
Bollinger Bands (100): | (40.86 - 48.8) | Sell |
RFFC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.18 | Buy |
20-day SMA: | 53.62 | Buy |
50-day SMA: | 52.59 | Buy |
200-day SMA: | 48.45 | Buy |
8-day EMA: | 54.12 | Buy |
20-day EMA: | 53.72 | Buy |
50-day EMA: | 52.92 | Buy |
200-day EMA: | 49.42 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.53 | Buy |
20-day SMA: | 40.36 | Sell |
50-day SMA: | 41.57 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.71 | Buy |
20-day EMA: | 40.38 | Sell |
50-day EMA: | 41.84 | Sell |
200-day EMA: | 43.38 | Sell |
ALPS Active Equity Opportunity ETF Earnings Growth & RFFC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
ALPS Active Equity Opportunity ETF Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |